These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16823938)

  • 21. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A solid-in-oil-in-water emulsion: An adjuvant-based immune-carrier enhances vaccine effect.
    Tahara Y; Mizuno R; Nishimura T; Mukai SA; Wakabayashi R; Kamiya N; Akiyoshi K; Goto M
    Biomaterials; 2022 Mar; 282():121385. PubMed ID: 35093824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the limits of adjuvanticity?
    Del Giudice G; Podda A; Rappuoli R
    Vaccine; 2001 Oct; 20 Suppl 1():S38-41. PubMed ID: 11587808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques.
    Phillips B; Van Rompay KKA; Rodriguez-Nieves J; Lorin C; Koutsoukos M; Tomai M; Fox CB; Eudailey J; Dennis M; Alam SM; Hudgens M; Fouda G; Pollara J; Moody A; Shen X; Ferrari G; Permar S; De Paris K
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells.
    Bonam SR; Platenburg PP; Bayry J
    Front Immunol; 2022; 13():1086752. PubMed ID: 36700217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Adjuvants and Immunomodulators for Veterinary Vaccines.
    Heegaard PM; Fang Y; Jungersen G
    Methods Mol Biol; 2016; 1349():63-82. PubMed ID: 26458830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squalene and squalane emulsions as adjuvants.
    Allison AC
    Methods; 1999 Sep; 19(1):87-93. PubMed ID: 10525443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of oil adjuvants in therapeutic vaccines.
    Aucouturier J; Ascarateil S; Dupuis L
    Vaccine; 2006 Apr; 24 Suppl 2():S2-44-5. PubMed ID: 16823921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4
    Schmidt ST; Neustrup MA; Harloff-Helleberg S; Korsholm KS; Rades T; Andersen P; Christensen D; Foged C
    Pharm Res; 2017 Aug; 34(8):1716-1727. PubMed ID: 28516400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental squalene adjuvant. I. Preparation and testing of its effectiveness.
    Süli J; Benísek Z; Eliás D; Svrcek S; Ondrejková A; Ondrejka R; Bajová V
    Vaccine; 2004 Sep; 22(25-26):3464-9. PubMed ID: 15308373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
    Yang YW; Wei AC; Shen SS
    Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manufacture of Oil-in-Water Emulsion Adjuvants.
    Haensler J
    Methods Mol Biol; 2017; 1494():165-180. PubMed ID: 27718193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses.
    Fox CB; Moutaftsi M; Vergara J; Desbien AL; Nana GI; Vedvick TS; Coler RN; Reed SG
    Vaccine; 2013 Dec; 31(49):5848-55. PubMed ID: 24120675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Innovation of vaccine adjuvants].
    Shimizu Y; Karamatsu K; Matsubara A; Yasutomi Y
    Nihon Rinsho; 2008 Oct; 66(10):1915-21. PubMed ID: 18939490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
    Ott G; Barchfeld GL; Van Nest G
    Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.